Literature DB >> 12902489

A catalytically inactive form of protein kinase C-associated kinase/receptor interacting protein 4, a protein kinase C beta-associated kinase that mediates NF-kappa B activation, interferes with early B cell development.

Annaiah Cariappa1, Luojing Chen, Khaleda Haider, Mei Tang, Eugene Nebelitskiy, Stewart T Moran, Shiv Pillai.   

Abstract

Protein kinase C-associated kinase (PKK)/receptor interacting protein 4 (RIP4) is a protein kinase C (PKC) beta-associated kinase that links PKC to NF-kappaB activation. The kinase domain of PKK is similar to that of RIP, RIP2, and RIP3. We show in this study that PKK is expressed early during lymphocyte development and can be detected in common lymphoid progenitor cells. Targeting of a catalytically inactive version of PKK to lymphoid cells resulted in a marked impairment in pro-B cell generation in the bone marrow. Although peripheral B cell numbers were markedly reduced, differentiation into follicular and marginal zone B cells was not defective in these mice. B-1a and B-1b B cells could not be detected in these mice, but this might be a reflection of the overall defect in B cell production observed in these animals. In keeping with a possible link to PKCbeta, peripheral B cells in these mice exhibit a defect in anti-IgM-mediated proliferation. These studies suggest that PKK may be required early in B cell development and for BCR-mediated B cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902489     DOI: 10.4049/jimmunol.171.4.1875

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Receptor-interacting protein (RIP) kinase family.

Authors:  Duanwu Zhang; Juan Lin; Jiahuai Han
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

2.  PKK deficiency in B cells prevents lupus development in Sle lupus mice.

Authors:  D Oleksyn; J Zhao; A Vosoughi; J C Zhao; R Misra; A P Pentland; D Ryan; J Anolik; C Ritchlin; J Looney; A P Anandarajah; G Schwartz; L M Calvi; M Georger; C Mohan; I Sanz; L Chen
Journal:  Immunol Lett       Date:  2017-03-06       Impact factor: 3.685

3.  Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms.

Authors:  A Zingone; C M Cultraro; D-M Shin; C M Bean; H C Morse; S Janz; W M Kuehl
Journal:  Leukemia       Date:  2010-04-15       Impact factor: 11.528

Review 4.  IKK-related genetic diseases: probing NF-κB functions in humans and other matters.

Authors:  Anna Senegas; Jérémie Gautheron; Alice Gentil Dit Maurin; Gilles Courtois
Journal:  Cell Mol Life Sci       Date:  2014-11-29       Impact factor: 9.261

5.  Protein kinase Cβ is required for lupus development in Sle mice.

Authors:  David Oleksyn; Mary Pulvino; Jiyong Zhao; Ravi Misra; Aram Vosoughi; Scott Jenks; Christopher Tipton; Frances Lund; George Schwartz; Bruce Goldman; Chandra Mohan; Kamal Mehta; Madhu Mehta; Michael Leitgets; Ignacio Sanz; Luojing Chen
Journal:  Arthritis Rheum       Date:  2013-04

6.  Deciphering the Functional Role of RIPK4 in Melanoma.

Authors:  Ewelina Madej; Damian Ryszawy; Anna A Brożyna; Malgorzata Czyz; Jaroslaw Czyz; Agnieszka Wolnicka-Glubisz
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

7.  RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation.

Authors:  Marina S Vivarelli; Douglas McDonald; Mendy Miller; Nicole Cusson; Michelle Kelliher; Raif S Geha
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.